These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23643233)

  • 1. Using the 7-point checklist as a diagnostic aid for pigmented skin lesions in general practice: a diagnostic validation study.
    Walter FM; Prevost AT; Vasconcelos J; Hall PN; Burrows NP; Morris HC; Kinmonth AL; Emery JD
    Br J Gen Pract; 2013 May; 63(610):e345-53. PubMed ID: 23643233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial.
    Walter FM; Morris HC; Humphrys E; Hall PN; Prevost AT; Burrows N; Bradshaw L; Wilson EC; Norris P; Walls J; Johnson M; Kinmonth AL; Emery JD
    BMJ; 2012 Jul; 345():e4110. PubMed ID: 22763392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of SIAscopy for pigmented skin lesions encountered in primary care: development and validation of a new diagnostic algorithm.
    Emery JD; Hunter J; Hall PN; Watson AJ; Moncrieff M; Walter FM
    BMC Dermatol; 2010 Sep; 10():9. PubMed ID: 20868511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leveraging AI and patient metadata to develop a novel risk score for skin cancer detection.
    Islam S; Wishart GC; Walls J; Hall P; Seco de Herrera AG; Gan JQ; Raza H
    Sci Rep; 2024 Sep; 14(1):20842. PubMed ID: 39242690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol for the MoleMate UK Trial: a randomised controlled trial of the MoleMate system in the management of pigmented skin lesions in primary care [ISRCTN 79932379].
    Walter FM; Morris HC; Humphrys E; Hall PN; Kinmonth AL; Prevost AT; Wilson EC; Burrows N; Norris P; Johnson M; Emery J
    BMC Fam Pract; 2010 May; 11():36. PubMed ID: 20459846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telemedicine in dermatology: a randomised controlled trial.
    Bowns IR; Collins K; Walters SJ; McDonagh AJ
    Health Technol Assess; 2006 Nov; 10(43):iii-iv, ix-xi, 1-39. PubMed ID: 17049140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Teledermatology for diagnosing skin cancer in adults.
    Chuchu N; Dinnes J; Takwoingi Y; Matin RN; Bayliss SE; Davenport C; Moreau JF; Bassett O; Godfrey K; O'Sullivan C; Walter FM; Motley R; Deeks JJ; Williams HC;
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD013193. PubMed ID: 30521686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of aid to diagnosis of pigmented skin lesions in general practice: controlled trial randomised by practice.
    English DR; Burton RC; del Mar CB; Donovan RJ; Ireland PD; Emery G
    BMJ; 2003 Aug; 327(7411):375. PubMed ID: 12919990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of humans versus mobile phone-powered artificial intelligence for the diagnosis and management of pigmented skin cancer in secondary care: a multicentre, prospective, diagnostic, clinical trial.
    Menzies SW; Sinz C; Menzies M; Lo SN; Yolland W; Lingohr J; Razmara M; Tschandl P; Guitera P; Scolyer RA; Boltz F; Borik-Heil L; Herbert Chan H; Chromy D; Coker DJ; Collgros H; Eghtedari M; Corral Forteza M; Forward E; Gallo B; Geisler S; Gibson M; Hampel A; Ho G; Junez L; Kienzl P; Martin A; Moloney FJ; Regio Pereira A; Ressler JM; Richter S; Silic K; Silly T; Skoll M; Tittes J; Weber P; Weninger W; Weiss D; Woo-Sampson P; Zilberg C; Kittler H
    Lancet Digit Health; 2023 Oct; 5(10):e679-e691. PubMed ID: 37775188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The U.K. skin cancer 'two-week rule' proforma: assessment of potential modifications to improve referral accuracy.
    Cox NH; Madan V; Sanders T
    Br J Dermatol; 2008 Jun; 158(6):1293-8. PubMed ID: 18363747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cost-effectiveness of a novel SIAscopic diagnostic aid for the management of pigmented skin lesions in primary care: a decision-analytic model.
    Wilson EC; Emery JD; Kinmonth AL; Prevost AT; Morris HC; Humphrys E; Hall PN; Burrows N; Bradshaw L; Walls J; Norris P; Johnson M; Walter FM
    Value Health; 2013; 16(2):356-66. PubMed ID: 23538188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of dermoscopy and short-term sequential digital dermoscopy imaging for the management of pigmented lesions in primary care: a sequential intervention trial.
    Menzies SW; Emery J; Staples M; Davies S; McAvoy B; Fletcher J; Shahid KR; Reid G; Avramidis M; Ward AM; Burton RC; Elwood JM
    Br J Dermatol; 2009 Dec; 161(6):1270-7. PubMed ID: 19747359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-point checklist for skin cancer detection in primary care.
    Moscarella E; Lallas A; Longo C; Alfano R; Argenziano G
    G Ital Dermatol Venereol; 2019 Oct; 154(5):523-528. PubMed ID: 28209049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of the revised seven-point checklist for the early diagnosis of cutaneous malignant melanoma.
    Healsmith MF; Bourke JF; Osborne JE; Graham-Brown RA
    Br J Dermatol; 1994 Jan; 130(1):48-50. PubMed ID: 8305316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic ability of general practitioners and dermatologists in discriminating pigmented skin lesions.
    Brochez L; Verhaeghe E; Bleyen L; Naeyaert JM
    J Am Acad Dermatol; 2001 Jun; 44(6):979-86. PubMed ID: 11369910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical predictors of malignant pigmented lesions. A comparison of the Glasgow seven-point checklist and the American Cancer Society's ABCDs of pigmented lesions.
    McGovern TW; Litaker MS
    J Dermatol Surg Oncol; 1992 Jan; 18(1):22-6. PubMed ID: 1740563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the value of the seven-point checklist in distinguishing benign pigmented lesions from melanoma.
    Keefe M; Dick DC; Wakeel RA
    Clin Exp Dermatol; 1990 May; 15(3):167-71. PubMed ID: 2142028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of a spectrophotometric intracutaneous analysis device in the real-time diagnosis of melanoma in the setting of a melanoma screening clinic.
    Haniffa MA; Lloyd JJ; Lawrence CM
    Br J Dermatol; 2007 Jun; 156(6):1350-2. PubMed ID: 17535234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exfoliative cytology for diagnosing basal cell carcinoma and other skin cancers in adults.
    Ferrante di Ruffano L; Dinnes J; Chuchu N; Bayliss SE; Takwoingi Y; Davenport C; Matin RN; O'Sullivan C; Roskell D; Deeks JJ; Williams HC;
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD013187. PubMed ID: 30521689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of dermoscopic patterns in detecting malignant melanoma on acral volar skin: results of a multicenter study in Japan.
    Saida T; Miyazaki A; Oguchi S; Ishihara Y; Yamazaki Y; Murase S; Yoshikawa S; Tsuchida T; Kawabata Y; Tamaki K
    Arch Dermatol; 2004 Oct; 140(10):1233-8. PubMed ID: 15492186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.